Dev Labtech Venture Limited announced the execution of a comprehensive term loan agreement with Small Industries Development Bank of India (SIDBI) on March 27, 2026. This development follows the company's earlier board approval for capital restructuring and business expansion initiatives aimed at enhancing liquidity and strengthening financial capabilities.

Term Loan Agreement Execution

The company has successfully executed a Term Loan Cum Hypothecation agreement along with other ancillary agreements with SIDBI for financial assistance. The loan facility will support the company's expansion plans and working capital requirements as part of its comprehensive restructuring strategy.

Security and Guarantee Structure

The loan agreement includes comprehensive security arrangements to protect the lender's interests. The primary security consists of a first charge by way of hypothecation on all movable properties of the borrower pertaining to the project, situated at Plot No 53, 54, 1st Floor, Thakordwar Society, Mini Bazar, Varachha Road, Surat, Gujarat-395006.

Capital Restructuring Framework

As part of the broader restructuring plan, the board had earlier approved increasing authorized share capital from Rs. 15,00,00,000 to Rs. 25,00,00,000, implementing a 1:2 share split followed by a 1:1 bonus issue. The company also approved amendments to its Memorandum of Association to expand into food products business and shipping operations.

Regulatory Compliance and Implementation

The loan execution was communicated to BSE Limited on March 28, 2026, in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015. Company Secretary Pankaj Pandav confirmed that the agreement does not contain terms pertaining to director appointment rights, share subscription rights, or capital structure restrictions. All restructuring initiatives remain subject to shareholder approval through postal ballot, with Mr. Ricky Kapadia appointed as scrutinizer for the voting process.

Dev Labtech Venture Limited has announced a board meeting scheduled for March 27, 2026, at 03:00 p.m. to consider several significant corporate restructuring proposals. The meeting will be held at the company's office located at Plot No 53-54, 1st Floor, Thakordwar Society, Mini Bazar, Varachha Road, Surat-395006, Gujarat.

Board Meeting Agenda

The board meeting has been convened under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, to address four major business items that could significantly impact the company's capital structure.

Regulatory Compliance Measures

In accordance with insider trading prevention protocols, Dev Labtech Venture Limited has implemented a trading window closure effective March 19, 2026. This closure aligns with the company's Code of Conduct for Monitoring and Prevention of Insider Trading, adopted in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

The trading window will remain closed until 48 hours after the conclusion of the board meeting on March 27, 2026. This measure ensures compliance with regulatory requirements and prevents any potential insider trading activities during the period of material information consideration.

Corporate Structure Implications

The proposed agenda items represent comprehensive corporate restructuring initiatives. The increase in authorized share capital and MOA amendments would provide the company with enhanced financial flexibility. The share subdivision proposal could improve liquidity by making shares more accessible to retail investors, while the bonus share issuance would reward existing equity shareholders.

All proposed measures are subject to requisite regulatory approvals and shareholder consent where applicable. The company has notified BSE Limited about the board meeting, with the stock trading under scrip code 543848 on the BSE SME platform.